Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies
<p><strong>Background</strong><br> For blood-stage malaria vaccine development, the in vitro growth inhibition assay (GIA) has been widely used to evaluate functionality of vaccine-induced antibodies (Ab), and <em>Plasmodium falciparum</em> reticulocyte-binding pr...
Main Authors: | Miura, K, Diouf, A, Fay, MP, Barrett, JR, Payne, RO, Olotu, AI, Minassian, AM, Silk, SE, Draper, SJ, Long, CA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2023
|
Similar Items
-
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies
by: Kazutoyo Miura, et al.
Published: (2023-05-01) -
Neutralization of Plasmodium falciparum merozoites by antibodies against PfRH5.
by: Douglas, A, et al.
Published: (2014) -
Kinetics of antibody responses to PfRH5-complex antigens in Ghanaian children with Plasmodium falciparum malaria
by: Partey, F, et al.
Published: (2018) -
Targeting PfRh5 on Merozoites to Prevent Basigin Binding
by: Papadopoulos Konstantinos
Published: (2012-10-01) -
A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants
by: Bustamante, L, et al.
Published: (2013)